Pharmacokinetics and the optimal regimen for levofloxacin in critically ill patients receiving continuous hemodiafiltration

The aim of this study was to establish the pharmacokinetics of levofloxacin (LVFX) and determine the optimal dose of this drug in critically ill patients receiving continuous hemodiafiltration (CHDF). The results of in vivo and in vitro studies showed the pharmacokinetics of LVFX total clearance (CL...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Intensive Care
Autors principals: Wada, Takeshi, Kobayashi, Masaki, Ono, Yuichi, Mizugaki, Asumi, Katabami, Kenichi, Maekawa, Kunihiko, Miyamoto, Daisuke, Yanagida, Yuichiro, Hayakawa, Mineji, Sawamura, Atsushi, Iseki, Ken, Gando, Satoshi
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2015
Matèries:
Letter to the Editor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436099/
https://ncbi.nlm.nih.gov/pubmed/25992293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40560-015-0089-0
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars